238 related articles for article (PubMed ID: 15868117)
1. Obesity, hypertension and insulin resistance.
Sharma AM; Chetty VT
Acta Diabetol; 2005 Apr; 42 Suppl 1():S3-8. PubMed ID: 15868117
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
3. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
5. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
6. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
9. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
10. Adipotoxicity and the insulin resistance syndrome.
Anderwald C; Roden M
Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
[TBL] [Abstract][Full Text] [Related]
11. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
Calabro P; Yeh ET
Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
[TBL] [Abstract][Full Text] [Related]
13. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
14. The inflammatory process of adipose tissue.
Blüher M
Pediatr Endocrinol Rev; 2008 Sep; 6(1):24-31. PubMed ID: 18806722
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of insulin resistance and associated diseases.
Mlinar B; Marc J; Janez A; Pfeifer M
Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
[TBL] [Abstract][Full Text] [Related]
16. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension.
Pausova Z
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):173-8. PubMed ID: 16481885
[TBL] [Abstract][Full Text] [Related]
17. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
18. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
Alam I; Lewis K; Stephens JW; Baxter JN
Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
Tankó LB; Christiansen C
Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
